RNAs in the Virion of Kaposi's Sarcoma-Associated Herpesvirus

ABSTRACT De novo infection of cultured cells with Kaposi's sarcoma-associated herpesvirus (KSHV) typically results in a latent infection. Recently, however, it has been reported that a subset of lytic mRNAs can be detected in cells shortly after KSHV infection; this expression is transient and eventually subsides, leading to latent infection (H. H. Krishnan et al., J. Virol 78:3601-3620, 2004). Since it has been shown that viral RNAs can be packaged into other herpesvirus virions, we sought to determine if KSHV virions contained RNAs and, if so, whether these RNAs contributed to the pool of lytic transcripts detected immediately after infection. Using DNA microarray, reverse transcription (RT)-PCR, and Northern blotting analyses, we identified 11 virally encoded RNAs in KSHV virions. These corresponded in size to the full-length mRNAs found in cytoplasmic RNA, and at least one was directly demonstrated to be translated upon infection in the presence of actinomycin D. Ten of these RNAs correspond to transcripts reported by Krishnan et al. at early times of infection, representing ca. 30% of such RNAs. Thus, import of RNAs in virions can account for some but not all of the early-appearing lytic transcripts. Quantitative RT-PCR analysis of infected-cell RNA demonstrated that most of the virion RNAs were very abundant at late times of infection, consistent with nonspecific incorporation during budding. However, the intracellular levels of one virion mRNA, encoding the viral protease, were much lower than those of transcripts not packaged in the virus particle, strongly suggesting that it may be incorporated by a specific mechanism.

[1]  D. Ganem,et al.  Host and Viral Proteins in the Virion of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.

[2]  T. Shenk,et al.  RNAs Are Packaged into Human Cytomegalovirus Virions in Proportion to Their Intracellular Concentration , 2004, Journal of Virology.

[3]  Yan Wang,et al.  Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: cis-Acting Requirements for Replication and ori-Lyt-Associated RNA Transcription , 2004, Journal of Virology.

[4]  B. Chandran,et al.  Concurrent Expression of Latent and a Limited Number of Lytic Genes with Immune Modulation and Antiapoptotic Function by Kaposi's Sarcoma-Associated Herpesvirus Early during Infection of Primary Endothelial and Fibroblast Cells and Subsequent Decline of Lytic Gene Expression , 2004, Journal of Virology.

[5]  D. Ganem,et al.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.

[6]  Shou-Jiang Gao,et al.  Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells , 2003, Journal of Virology.

[7]  D. Kedes,et al.  Surface Downregulation of Major Histocompatibility Complex Class I, PE-CAM, and ICAM-1 following De Novo Infection of Endothelial Cells with Kaposi's Sarcoma-Associated Herpesvirus , 2003, Journal of Virology.

[8]  S. M. Akula,et al.  Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Infection of Human Fibroblast Cells Occurs through Endocytosis , 2003, Journal of Virology.

[9]  D. Ganem,et al.  Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.

[10]  H. Kung,et al.  K-bZIP of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 (KSHV/HHV-8) Binds KSHV/HHV-8 Rta and Represses Rta-Mediated Transactivation , 2003, Journal of Virology.

[11]  H. Kung,et al.  Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Is a Coregulator of K-Rta: Physical Association and Promoter-Dependent Transcriptional Repression , 2003, Journal of Virology.

[12]  F. Cohen,et al.  Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray , 2003, Genome Biology.

[13]  Shou-Jiang Gao,et al.  Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis , 2002, Journal of Virology.

[14]  B. Roizman,et al.  Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Tyson V. Sharp,et al.  Characterization of an anti‐apoptotic glycoprotein encoded by Kaposi's sarcoma‐associated herpesvirus which resembles a spliced variant of human survivin , 2002, The EMBO journal.

[16]  M. McMahon,et al.  De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells , 2002, Journal of Virology.

[17]  Shaw M. Akula,et al.  Integrin α3β1 (CD 49c/29) Is a Cellular Receptor for Kaposi's Sarcoma-Associated Herpesvirus (KSHV/HHV-8) Entry into the Target Cells , 2002, Cell.

[18]  B. Roizman,et al.  RNAs Extracted from Herpes Simplex Virus 1 Virions: Apparent Selectivity of Viral but Not Cellular RNAs Packaged in Virions , 2001, Journal of Virology.

[19]  Frederick Y. Wu,et al.  Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.

[20]  B. Chandran,et al.  Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.

[21]  M. Borowitz,et al.  A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant , 2000, Journal of Virology.

[22]  Jaap M Middeldorp,et al.  Human Cytomegalovirus Virions Differentially Incorporate Viral and Host Cell RNA during the Assembly Process , 2000, Journal of Virology.

[23]  D. Ganem,et al.  On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 2000, The Journal of general virology.

[24]  Sarah Nikiforow,et al.  Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line , 2000, Journal of Virology.

[25]  T. Shenk,et al.  A subset of viral transcripts packaged within human cytomegalovirus particles. , 2000, Science.

[26]  B. Chandran,et al.  Long-Term Infection and Transformation of Dermal Microvascular Endothelial Cells by Human Herpesvirus 8 , 1999, Journal of Virology.

[27]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[28]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[29]  G. Pari,et al.  Identification of Persistent RNA-DNA Hybrid Structures within the Origin of Replication of Human Cytomegalovirus , 1998, Journal of Virology.

[30]  F. Neipel,et al.  The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. , 1998, Journal of virology.

[31]  B. Chandran,et al.  Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. , 1998, Virology.

[32]  L. Corey,et al.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma , 1997, Journal of virology.

[33]  C. Craik,et al.  The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) , 1997, Journal of virology.

[34]  W. Zhong,et al.  The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.

[35]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[36]  R. Sun,et al.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. , 1996, The New England journal of medicine.

[37]  S. Rafii,et al.  Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells , 1996, The Journal of experimental medicine.

[38]  E. Cesarman,et al.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. , 1995, Blood.

[39]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[40]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.

[41]  D. Ganem,et al.  Host and Viral Proteins in the Virion of Kaposi's Sarcoma-Associated Herpesvirus , 2005, Journal of Virology.

[42]  T. Shenk,et al.  RNAs Are Packaged into Human Cytomegalovirus Virions in Proportion to Their Intracellular Concentration , 2004, Journal of Virology.

[43]  Yan Wang,et al.  Kaposi's Sarcoma-Associated Herpesvirus ori-Lyt-Dependent DNA Replication: cis-Acting Requirements for Replication and ori-Lyt-Associated RNA Transcription , 2004, Journal of Virology.

[44]  B. Chandran,et al.  Concurrent Expression of Latent and a Limited Number of Lytic Genes with Immune Modulation and Antiapoptotic Function by Kaposi's Sarcoma-Associated Herpesvirus Early during Infection of Primary Endothelial and Fibroblast Cells and Subsequent Decline of Lytic Gene Expression , 2004, Journal of Virology.

[45]  D. Ganem,et al.  Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. , 2004, Molecular cell.

[46]  Shou-Jiang Gao,et al.  Productive Lytic Replication of a Recombinant Kaposi's Sarcoma-Associated Herpesvirus in Efficient Primary Infection of Primary Human Endothelial Cells , 2003, Journal of Virology.

[47]  D. Kedes,et al.  Surface Downregulation of Major Histocompatibility Complex Class I, PE-CAM, and ICAM-1 following De Novo Infection of Endothelial Cells with Kaposi's Sarcoma-Associated Herpesvirus , 2003, Journal of Virology.

[48]  S. M. Akula,et al.  Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Infection of Human Fibroblast Cells Occurs through Endocytosis , 2003, Journal of Virology.

[49]  D. Ganem,et al.  Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells , 2003, Journal of Virology.

[50]  H. Kung,et al.  K-bZIP of Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8 (KSHV/HHV-8) Binds KSHV/HHV-8 Rta and Represses Rta-Mediated Transactivation , 2003, Journal of Virology.

[51]  H. Kung,et al.  Kaposi's Sarcoma-Associated Herpesvirus K-bZIP Is a Coregulator of K-Rta: Physical Association and Promoter-Dependent Transcriptional Repression , 2003, Journal of Virology.

[52]  F. Cohen,et al.  Expression profiling of the schizont and trophozoite stages of Plasmodium falciparum with a long-oligonucleotide microarray , 2003, Genome Biology.

[53]  Shou-Jiang Gao,et al.  Efficient Infection by a Recombinant Kaposi's Sarcoma-Associated Herpesvirus Cloned in a Bacterial Artificial Chromosome: Application for Genetic Analysis , 2002, Journal of Virology.

[54]  B. Roizman,et al.  Of the three tegument proteins that package mRNA in herpes simplex virions, one (VP22) transports the mRNA to uninfected cells for expression prior to viral infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  Tyson V. Sharp,et al.  Characterization of an anti‐apoptotic glycoprotein encoded by Kaposi's sarcoma‐associated herpesvirus which resembles a spliced variant of human survivin , 2002, The EMBO journal.

[56]  M. McMahon,et al.  De Novo Infection and Serial Transmission of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Endothelial Cells , 2002, Journal of Virology.

[57]  S. M. Akula,et al.  Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) entry into the target cells. , 2002, Cell.

[58]  B. Roizman,et al.  RNAs Extracted from Herpes Simplex Virus 1 Virions: Apparent Selectivity of Viral but Not Cellular RNAs Packaged in Virions , 2001, Journal of Virology.

[59]  Frederick Y. Wu,et al.  Spindle Cell Conversion by Kaposi's Sarcoma-Associated Herpesvirus: Formation of Colonies and Plaques with Mixed Lytic and Latent Gene Expression in Infected Primary Dermal Microvascular Endothelial Cell Cultures , 2001, Journal of Virology.

[60]  B. Chandran,et al.  Activation of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Lytic Replication by Human Cytomegalovirus , 2001, Journal of Virology.

[61]  M. Borowitz,et al.  A New Primary Effusion Lymphoma-Derived Cell Line Yields a Highly Infectious Kaposi's Sarcoma Herpesvirus-Containing Supernatant , 2000, Journal of Virology.

[62]  Jaap M Middeldorp,et al.  Human Cytomegalovirus Virions Differentially Incorporate Viral and Host Cell RNA during the Assembly Process , 2000, Journal of Virology.

[63]  D. Ganem,et al.  On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). , 2000, The Journal of general virology.

[64]  Sarah Nikiforow,et al.  Kaposi's Sarcoma-Associated Herpesvirus Open Reading Frame 50/Rta Protein Activates the Entire Viral Lytic Cycle in the HH-B2 Primary Effusion Lymphoma Cell Line , 2000, Journal of Virology.

[65]  T. Shenk,et al.  A subset of viral transcripts packaged within human cytomegalovirus particles. , 2000, Science.

[66]  B. Chandran,et al.  Long-Term Infection and Transformation of Dermal Microvascular Endothelial Cells by Human Herpesvirus 8 , 1999, Journal of Virology.

[67]  M. Ballestas,et al.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. , 1999, Science.

[68]  R. Sun,et al.  A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. Pari,et al.  Identification of Persistent RNA-DNA Hybrid Structures within the Origin of Replication of Human Cytomegalovirus , 1998, Journal of Virology.

[70]  F. Neipel,et al.  The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. , 1998, Journal of virology.

[71]  B. Chandran,et al.  Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. , 1998, Virology.

[72]  L. Corey,et al.  Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma , 1997, Journal of virology.

[73]  C. Craik,et al.  The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) , 1997, Journal of virology.

[74]  W. Zhong,et al.  The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions , 1996, Journal of virology.

[75]  E. Operskalski,et al.  The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma–associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission , 1996, Nature Medicine.

[76]  R. Sun,et al.  Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. , 1996, The New England journal of medicine.

[77]  S. Rafii,et al.  Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells , 1996, The Journal of experimental medicine.

[78]  E. Cesarman,et al.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. , 1995, Blood.

[79]  E. Cesarman,et al.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. , 1995, The New England journal of medicine.

[80]  E. Cesarman,et al.  Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.